CompletedNCT01228175
Varenicline Compared With Placebo to Help People Stop Smoking
About this title
Read the official source — NCT01228175Medication studyAges 18–55United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- AlbuquerqueSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateMarch 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 218
- Sponsor
- The Mind Research Network
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01228175
- Official title
Show the full official title
Effectiveness of Varenicline: Testing Individual Differences
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Albuquerque
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The Mind Research Network.
Did this study involve medication?
Yes. The study involved medication, including Placebo and Varenicline.
Who was this study for?
Listed age limits: 18 years to 55 years.
